Sign in
4

Changes in Ownership

ENANTA PHARMACEUTICALS INC Filed Acc 0001062993-23-021384

Options or other derivatives

  • Sr. VP, New Prod. Strat. & Dev acquired 83,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Kieffer Tara Lynn · Sr. VP, New Prod. Strat. & Dev

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2023-11-22 Grant or award : show line 1 in the form Stock Option (right to buy) +83,000 83,000 D
Loading xslF345X05/form4.xml…